General principles for the formation and proliferation of a wall-free (L-form) state in bacteria

  1. Romain Mercier
  2. Yoshikazu Kawai
  3. Jeff Errington  Is a corresponding author
  1. Newcastle University, United Kingdom

Abstract

The peptidoglycan cell wall is a defining structural feature of the bacterial-kingdom. Curiously, some bacteria have the ability to switch to a wall-free or 'L-form' state. Although known for decades, the general properties of L-forms are poorly understood, largely due to the lack of their systematic analysis in the molecular biology era. Here we show that inhibition of the peptidoglycan precursor synthesis promotes the generation of L-forms from both Gram-positive and Gram-negative bacteria. We show that L-forms generated have in common a mechanism of proliferation involving membrane blebbing and tubulation, which is dependant on an altered rate of membrane synthesis. Crucially, this mode of proliferation is independent of the essential FtsZ-based division machinery. Our results suggest that the L-form mode of proliferation is conserved across the bacterial-kingdom, reinforcing the idea that it could have been used in primitive cells, and opening up its use in the generation of synthetic cells.

Article and author information

Author details

  1. Romain Mercier

    Newcastle University, Newcastle upon Tyne, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Yoshikazu Kawai

    Newcastle University, Newcastle upon Tyne, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Jeff Errington

    Newcastle University, Newcastle upon Tyne, United Kingdom
    For correspondence
    jeff.errington@newcastle.ac.uk
    Competing interests
    The authors declare that no competing interests exist.

Copyright

© 2014, Mercier et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,462
    views
  • 993
    downloads
  • 107
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Romain Mercier
  2. Yoshikazu Kawai
  3. Jeff Errington
(2014)
General principles for the formation and proliferation of a wall-free (L-form) state in bacteria
eLife 3:e04629.
https://doi.org/10.7554/eLife.04629

Share this article

https://doi.org/10.7554/eLife.04629

Further reading

  1. Some bacteria can survive and thrive despite not having a cell wall.

    1. Cell Biology
    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.